[{"address1": "1 New Burlington Place", "city": "London", "zip": "W1S 2HR", "country": "United Kingdom", "phone": "44 20 7399 2760", "website": "https://www.hikma.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.", "fullTimeEmployees": 9100, "companyOfficers": [{"maxAge": 1, "name": "Engineer Said Samih Taleb Darwazah", "age": 66, "title": "Executive Chairman", "yearBorn": 1957, "fiscalYear": 2023, "totalPay": 2800697, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Riad Ali Mishlawi", "age": 59, "title": "CEO & Director", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 1102924, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mazen Samih Taleb Darwazah", "age": 65, "title": "Executive Vice Chairman & President of MENA", "yearBorn": 1958, "fiscalYear": 2023, "totalPay": 2300340, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Khalid Waleed Hosny Al Nabilsi", "age": 51, "title": "Chief Financial Officer", "yearBorn": 1972, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Patricia  Bousfield", "title": "Chief Information Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Guy  Featherstone", "title": "Associate Director of Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Samuel  Park", "title": "General Counsel", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bassam Wael Rushdi Kanaan CFA, CPA", "age": 58, "title": "Executive Vice President of Corporate Development and M&A", "yearBorn": 1965, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Hussein Omar Arkhagha", "title": "Chief People Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Susan  Ringdal", "title": "Executive Vice President of Strategic Planning & Global Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 6, "compensationRisk": 1, "shareHolderRightsRisk": 1, "overallRisk": 3, "governanceEpochDate": 1725148800, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 25.55, "open": 25.55, "dayLow": 25.55, "dayHigh": 26.07, "regularMarketPreviousClose": 25.55, "regularMarketOpen": 25.55, "regularMarketDayLow": 25.55, "regularMarketDayHigh": 26.07, "dividendRate": 0.79, "dividendYield": 0.0304, "exDividendDate": 1723680000, "payoutRatio": 0.7275, "fiveYearAvgDividendYield": 2.03, "beta": 0.414, "trailingPE": 30.541174, "forwardPE": 11.238095, "volume": 4181, "regularMarketVolume": 4181, "averageVolume": 280, "averageVolume10days": 240, "averageDailyVolume10Day": 240, "bid": 25.59, "ask": 26.9, "bidSize": 27000, "askSize": 38800, "marketCap": 5760134144, "fiftyTwoWeekLow": 21.284, "fiftyTwoWeekHigh": 27.0, "priceToSalesTrailing12Months": 1.9092258, "fiftyDayAverage": 24.868456, "twoHundredDayAverage": 24.0211, "trailingAnnualDividendRate": 0.79, "trailingAnnualDividendYield": 0.030919766, "currency": "USD", "enterpriseValue": 6786567168, "profitMargins": 0.09446, "floatShares": 155247695, "sharesOutstanding": 221884992, "heldPercentInsiders": 0.30543, "heldPercentInstitutions": 0.42473, "bookValue": 10.309, "priceToBook": 2.518188, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "earningsQuarterlyGrowth": 0.725, "netIncomeToCommon": 285000000, "trailingEps": 0.85, "forwardEps": 2.31, "pegRatio": 8.05, "enterpriseToRevenue": 2.249, "enterpriseToEbitda": 8.041, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "HKMPF", "underlyingSymbol": "HKMPF", "shortName": "HIKMA PHARMACEUTICALS", "longName": "Hikma Pharmaceuticals PLC", "firstTradeDateEpochUtc": 1345642200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "ce333143-af7a-37d1-9a7a-c730d7456e2b", "gmtOffSetMilliseconds": -14400000, "currentPrice": 25.96, "recommendationMean": 2.0, "recommendationKey": "buy", "totalCash": 260000000, "totalCashPerShare": 1.173, "ebitda": 844000000, "totalDebt": 1276000000, "quickRatio": 0.888, "currentRatio": 1.656, "totalRevenue": 3016999936, "debtToEquity": 55.478, "revenuePerShare": 13.675, "returnOnAssets": 0.09402, "returnOnEquity": 0.12883, "freeCashflow": 410375008, "operatingCashflow": 584000000, "earningsGrowth": 0.712, "revenueGrowth": 0.1, "grossMargins": 0.47994998, "ebitdaMargins": 0.27975, "operatingMargins": 0.25621, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]